WebMar 9, 2024 · SAN DIEG O, March 9, 2024 (GLOBE NEWSWIRE) – Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2024 and revenue outlook for 2024. “We started the year against a challenging external backdrop, and over the course of the year achieved or exceeded all … WebMar 9, 2024 · Mar. 9, 2024, 05:35 PM. Bionano Genomics, Inc. (BNGO) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to loss of $0.08 per ...
Bionano Genomics, Inc. (BNGO) Reports Q4 Loss, Misses Revenue …
WebMar 9, 2024 · BioNano Genomics Inc (NASDAQ:BNGO) shares are trading marginally lower during Thursday's after-hours session after the company reported fourth-quarter … Web1 day ago · Bionano Genomics Reports Preliminary Fourth Quarter and Full-Year 2024 Results. - Preliminary Q4 revenue expected to be between $8.1 and $8.4 million; 29% to 33% increase over Q4 2024- Reached installed base of 240 systems as of YE 2024; 46% increase over YE 2024- Achieved or exc... 3 months ago - GlobeNewsWire. lawns classic car show
Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2024 Earnings Call …
WebBionano Genomics (BNGO) Q4 2024 Earnings Call Transcript. BNGO earnings call for the period ending December 31, 2024. Motley Fool Transcribing Mar 9, 2024 Web20 hours ago · Price To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for Bionano Genomics (BNGO) WebMar 13, 2024 · Revenues for the fourth quarter of 2024 were $8.2 million, which is up 30% versus the fourth quarter of 2024. Revenue for the full year was €“ 2024 was $27.8 … lawn scooper